{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:50:34Z","timestamp":1792929034678,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA238110"],"award-info":[{"award-number":["U54CA238110"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Electronic cigarettes (e-cigarettes) are widely promoted as harm-reduction products for smokers, and smokers commonly perceive them as less harmful than combustible cigarettes. One of the key questions regarding public health consequences of e-cigarettes is the magnitude of harm reduction achievable by smokers who switch from combustible cigarettes to e-cigarettes. We conducted a systematic literature review of epidemiological studies that estimated odds of respiratory and cardiovascular outcomes among former smokers who use e-cigarettes compared to current smokers.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This\u00a0systematic\u00a0review\u00a0was conducted in accordance with the Preferred Reporting Items for\u00a0Systematic\u00a0Review\u00a0and Meta-Analysis (PRISMA) statement<jats:bold>.<\/jats:bold> We searched the PubMed and Embase databases in September 2020 to identify epidemiological studies that compared odds of cardiovascular and respiratory outcomes among former smokers who transitioned to e-cigarettes relative to odds among current smokers not using e-cigarettes (current exclusive smokers). We included studies that provided direct estimates of relevant odds ratios (ORs). We also included studies where indirect estimates of relevant ORs could be calculated based on published results. Two reviewers independently extracted data and conducted quality appraisals.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Six population-based studies with sample sizes ranging from 19,475 to 161,529 respondents met review inclusion criteria, five of which were cross-sectional and one longitudinal. Three studies reported respiratory outcomes and three reported cardiovascular outcomes. ORs of respiratory outcomes (including chronic obstructive pulmonary disease, chronic bronchitis, emphysema, asthma, and wheezing) in former smokers who transitioned to e-cigarettes versus current exclusive smokers were below 1.0, ranging from 0.58 (95%CI 0.36\u20130.94) to 0.66 (95%CI 0.50\u20130.87; all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). All ORs for cardiovascular outcomes (including stroke, myocardial infarction, and coronary heart disease) did not differ significantly from 1.0.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Though our review included a small number of studies, it provided consistent results. Former smokers who transitioned to e-cigarettes showed\u2009~\u200940% lower odds of respiratory outcomes compared to current exclusive smokers. Switching from smoking to e-cigarette does not appear to significantly lower odds of cardiovascular outcomes. Since the utility of cross-sectional studies for causal inference remains limited, both randomized controlled trials and prospective cohort studies are needed to better evaluate contributions of e-cigarettes as harm reduction tools for smokers.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12954-020-00440-w","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T20:03:53Z","timestamp":1606161833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6748-3068","authenticated-orcid":false,"given":"Maciej L.","family":"Goniewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Sutanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"440_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/jamapediatrics.2015.3024","volume":"170","author":"MP Wang","year":"2016","unstructured":"Wang MP, Ho SY, Leung LT, et al. Electronic cigarette use and respiratory symptoms in Chinese adolescents in Hong Kong. JAMA Pediatr. 2016;170:89\u201391.","journal-title":"JAMA Pediatr"},{"key":"440_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1164\/rccm.201604-0804OC","volume":"195","author":"R McConnell","year":"2017","unstructured":"McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195:1043\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"440_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ypmed.2017.09.023","volume":"105","author":"RJ Schweitzer","year":"2017","unstructured":"Schweitzer RJ, Wills TA, Tam E, et al. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med. 2017;105:226\u201331.","journal-title":"Prev Med"},{"key":"440_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.amepre.2016.03.010","volume":"51","author":"K Choi","year":"2016","unstructured":"Choi K, Bernat D. E-cigarette use among Florida youth with and without asthma. Am J Prev Med. 2016;51:446\u201353.","journal-title":"Am J Prev Med"},{"key":"440_CR5","doi-asserted-by":"publisher","first-page":"e0151022","DOI":"10.1371\/journal.pone.0151022","volume":"11","author":"JH Cho","year":"2016","unstructured":"Cho JH, Paik SY. Association between electronic cigarette use and asthma among high school students in South Korea. PLoS ONE. 2016;11:e0151022.","journal-title":"PLoS ONE"},{"key":"440_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"SY Kim","year":"2017","unstructured":"Kim SY, Sim S, Choi HG. Active, passive, and electronic cigarette smoking is associated with asthma in adolescents. Sci Rep. 2017;7:1\u20138.","journal-title":"Sci Rep"},{"key":"440_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.15585\/mmwr.mm6806e1","volume":"68","author":"AS Gentzke","year":"2019","unstructured":"Gentzke AS, Creamer M, Cullen KA, et al. Vital signs: tobacco product use among middle and high school students\u2014United States, 2011\u20132018. Morb Mortal Wkly Rep. 2019;68:157.","journal-title":"Morb Mortal Wkly Rep"},{"key":"440_CR8","doi-asserted-by":"crossref","unstructured":"Hammond D, Reid JL, Rynard VL, et al. Prevalence of vaping and smoking among adolescents in Canada, England, and the United States: repeat national cross sectional surveys. BMJ. 2019;365","DOI":"10.1136\/bmj.l2219"},{"key":"440_CR9","doi-asserted-by":"publisher","first-page":"s191","DOI":"10.1136\/tobaccocontrol-2020-055671","volume":"29","author":"KA Kasza","year":"2020","unstructured":"Kasza KA, Edwards KC, Tang Z, et al. Correlates of tobacco product initiation among youth and adults in the USA: findings from the PATH Study Waves 1\u20133 (2013\u20132016). Tob Control. 2020;29:s191\u2013202.","journal-title":"Tob Control"},{"key":"440_CR10","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jamainternmed.2020.2817","volume":"180","author":"OH Obisesan","year":"2020","unstructured":"Obisesan OH, Osei AD, Uddin SI, et al. Trends in e-cigarette use in adults in the United States, 2016\u20132018. JAMA Int Med. 2020;180:1394\u20138.","journal-title":"JAMA Int Med"},{"key":"440_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00386-z","volume":"17","author":"L Wei","year":"2020","unstructured":"Wei L, Muhammad-Kah RS, Hannel T, et al. The impact of cigarette and e-cigarette use history on transition patterns: a longitudinal analysis of the population assessment of tobacco and health (PATH) study, 2013\u20132015. Harm Reduct J. 2020;17:1\u201312.","journal-title":"Harm Reduct J"},{"key":"440_CR12","doi-asserted-by":"crossref","unstructured":"Chen R, Pierce JP, Leas EC, et al. E-cigarette use to aid long-term smoking cessation in the US: prospective evidence from the PATH Cohort Study. Am J Epidemiol. 2020.","DOI":"10.1093\/aje\/kwaa161"},{"key":"440_CR13","doi-asserted-by":"crossref","unstructured":"Kyriakos CN, Filippidis FT, Hitchman S, et al. Characteristics and correlates of electronic cigarette product attributes and undesirable events during e-cigarette use in six countries of the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2018;16:A1.","DOI":"10.18332\/tid\/93545"},{"key":"440_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/2042098614524430","volume":"5","author":"KE Farsalinos","year":"2014","unstructured":"Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5:67\u201386.","journal-title":"Ther Adv Drug Saf"},{"key":"440_CR15","volume-title":"Public health consequences of e-cigarettes","author":"National Academies of Sciences, Engineering, and Medicine","year":"2018","unstructured":"National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. Washington: National Academies Press; 2018."},{"key":"440_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/tobaccocontrol-2012-050859","volume":"23","author":"ML Goniewicz","year":"2014","unstructured":"Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133\u20139.","journal-title":"Tob Control"},{"key":"440_CR17","doi-asserted-by":"publisher","first-page":"e0234189","DOI":"10.1371\/journal.pone.0234189","volume":"15","author":"AM Ward","year":"2020","unstructured":"Ward AM, Yaman R, Ebbert JO. Electronic nicotine delivery system design and aerosol toxicants: a systematic review. PLoS ONE. 2020;15:e0234189.","journal-title":"PLoS ONE"},{"key":"440_CR18","doi-asserted-by":"publisher","first-page":"ii11","DOI":"10.1136\/tobaccocontrol-2013-051482","volume":"23","author":"T Cheng","year":"2014","unstructured":"Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23:ii11\u20137.","journal-title":"Tob Control"},{"key":"440_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3389\/fphys.2017.01119","volume":"8","author":"KE Farsalinos","year":"2018","unstructured":"Farsalinos KE, Gillman G. Carbonyl emissions in e-cigarette aerosol: a systematic review and methodological considerations. Front Physiol. 2018;8:1119. https:\/\/doi.org\/10.3389\/fphys.2017.01119.","journal-title":"Front Physiol"},{"key":"440_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/08958378.2019.1671558","volume":"31","author":"G Wang","year":"2019","unstructured":"Wang G, Liu W, Song W. Toxicity assessment of electronic cigarettes. Inhal Toxicol. 2019;31:259\u201373.","journal-title":"Inhal Toxicol"},{"key":"440_CR21","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.3390\/ijerph120403915","volume":"12","author":"S Scheffler","year":"2015","unstructured":"Scheffler S, Dieken H, Krischenowski O, et al. Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health. 2015;12:3915\u201325.","journal-title":"Int J Environ Res Public Health"},{"key":"440_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3109\/08958378.2013.793439","volume":"25","author":"G Romagna","year":"2013","unstructured":"Romagna G, Allifranchini E, Bocchietto E, et al. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol. 2013;25:354\u201361.","journal-title":"Inhal Toxicol"},{"key":"440_CR23","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.tiv.2014.04.012","volume":"28","author":"F Cervellati","year":"2014","unstructured":"Cervellati F, Muresan XM, Sticozzi C, et al. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol In Vitro. 2014;28:999\u20131005.","journal-title":"Toxicol In Vitro"},{"key":"440_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-016-0447-z","volume":"17","author":"PS Hiemstra","year":"2016","unstructured":"Hiemstra PS, Bals R. Basic science of electronic cigarettes: assessment in cell culture and in vivo models. Respir Res. 2016;17:1\u20135.","journal-title":"Respir Res"},{"key":"440_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ntr\/ntv169","volume":"18","author":"A Husari","year":"2016","unstructured":"Husari A, Shihadeh A, Talih S, et al. Acute exposure to electronic and combustible cigarette aerosols: effects in an animal model and in human alveolar cells. Nicotine Tob Res. 2016;18:613\u20139.","journal-title":"Nicotine Tob Res"},{"key":"440_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/ijms21020652","volume":"21","author":"A Merecz-Sadowska","year":"2020","unstructured":"Merecz-Sadowska A, Sitarek P, Zielinska-Blizniewska H, et al. A Summary of In Vitro and In Vivo studies evaluating the impact of e-cigarette exposure on living organisms and the environment. Int J Mol Sci. 2020;21:652.","journal-title":"Int J Mol Sci"},{"key":"440_CR27","doi-asserted-by":"publisher","first-page":"e185937","DOI":"10.1001\/jamanetworkopen.2018.5937","volume":"1","author":"ML Goniewicz","year":"2018","unstructured":"Goniewicz ML, Smith DM, Edwards KC, et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018;1:e185937\u2013e185937. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.5937.","journal-title":"JAMA Netw Open"},{"key":"440_CR28","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1158\/1055-9965.EPI-17-0460","volume":"26","author":"MJ Carpenter","year":"2017","unstructured":"Carpenter MJ, Heckman BW, Wahlquist AE, et al. A naturalistic, randomized pilot trial of e-cigarettes: uptake, exposure, and behavioral effects. Cancer Epidemiol Prev Biomark. 2017;26:1795\u2013803.","journal-title":"Cancer Epidemiol Prev Biomark"},{"key":"440_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.7326\/M16-1107","volume":"166","author":"L Shahab","year":"2017","unstructured":"Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med. 2017;166:390\u2013400.","journal-title":"Ann Intern Med"},{"key":"440_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/ntr\/ntw160","volume":"19","author":"ML Goniewicz","year":"2017","unstructured":"Goniewicz ML, Gawron M, Smith DM, et al. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19:160\u20137.","journal-title":"Nicotine Tob Res"},{"key":"440_CR31","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1016\/j.jacc.2019.09.067","volume":"74","author":"J George","year":"2019","unstructured":"George J, Hussain M, Vadiveloo T, et al. Cardiovascular effects of switching from tobacco cigarettes to electronic cigarettes. J Am Coll Cardiol. 2019;74:3112\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.067.","journal-title":"J Am Coll Cardiol"},{"key":"440_CR32","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"440_CR33","doi-asserted-by":"publisher","first-page":"e011458","DOI":"10.1136\/bmjopen-2016-011458","volume":"6","author":"MJ Downes","year":"2016","unstructured":"Downes MJ, Brennan ML, Williams HC, et al. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6:e011458.","journal-title":"BMJ Open"},{"key":"440_CR34","doi-asserted-by":"publisher","first-page":"e180789","DOI":"10.1001\/jamanetworkopen.2018.0789","volume":"1","author":"L Hedman","year":"2018","unstructured":"Hedman L, Backman H, Stridsman C, et al. Association of electronic cigarette use with smoking habits, demographic factors, and respiratory symptoms. JAMA Netw Open. 2018;1:e180789\u2013e180789. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0789.","journal-title":"JAMA Netw Open"},{"key":"440_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/tobaccocontrol-2018-054694","volume":"29","author":"D Li","year":"2020","unstructured":"Li D, Sundar IK, McIntosh S, et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2. Tob Control. 2020;29:140\u20137. https:\/\/doi.org\/10.1136\/tobaccocontrol-2018-054694.","journal-title":"Tob Control"},{"key":"440_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.amepre.2019.07.028","volume":"58","author":"DN Bhatta","year":"2020","unstructured":"Bhatta DN, Glantz SA. Association of e-cigarette use with respiratory disease among adults: a longitudinal analysis. Am J Prev Med. 2020;58:182\u201390. https:\/\/doi.org\/10.1016\/j.amepre.2019.07.028.","journal-title":"Am J Prev Med"},{"key":"440_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.amepre.2018.05.004","volume":"55","author":"T Alzahrani","year":"2018","unstructured":"Alzahrani T, Pena I, Temesgen N, et al. Association between electronic cigarette use and myocardial infarction. Am J Prev Med. 2018;55:455\u201361. https:\/\/doi.org\/10.1016\/j.amepre.2018.05.004.","journal-title":"Am J Prev Med"},{"key":"440_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2040622319877741","volume":"10","author":"KE Farsalinos","year":"2019","unstructured":"Farsalinos KE, Polosa R, Cibella F, et al. Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys. Ther Adv Chronic Dis. 2019;10:1\u201310. https:\/\/doi.org\/10.1177\/2040622319877741.","journal-title":"Ther Adv Chronic Dis"},{"key":"440_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.amepre.2019.10.008","volume":"58","author":"T Parekh","year":"2020","unstructured":"Parekh T, Pemmasani S, Desai R. Risk of stroke with e-cigarette and combustible cigarette use in young adults. Am J Prev Med. 2020;58:446\u201352. https:\/\/doi.org\/10.1016\/j.amepre.2019.10.008.","journal-title":"Am J Prev Med"},{"key":"440_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2288-10-66","volume":"10","author":"ME Reichenheim","year":"2010","unstructured":"Reichenheim ME, Coutinho ES. Measures and models for causal inference in cross-sectional studies: arguments for the appropriateness of the prevalence odds ratio and related logistic regression. BMC Med Res Methodol. 2010;10:66. https:\/\/doi.org\/10.1186\/1471-2288-10-66.","journal-title":"BMC Med Res Methodol"},{"key":"440_CR41","unstructured":"US Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center on Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010"},{"key":"440_CR42","unstructured":"US Department of Health and Human Services. The health consequences of smoking\u201450 years of progress: a report of the surgeon general. Atlanta, GA: Centers for Disease Control and Prevention, National Center on Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014"},{"key":"440_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.pu.09.050188.002315","volume":"9","author":"DC Thomas","year":"1988","unstructured":"Thomas DC. Models for exposure-time-response relationships with applications to cancer epidemiology. Annu Rev Public Health. 1988;9:451\u201382.","journal-title":"Annu Rev Public Health"},{"key":"440_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"S Wu","year":"2018","unstructured":"Wu S, Zhu W, Thompson P, et al. Evaluating intrinsic and non-intrinsic cancer risk factors. Nat Commun. 2018;9:1\u201312.","journal-title":"Nat Commun"},{"key":"440_CR45","doi-asserted-by":"crossref","unstructured":"Luo J, Hendryx M, Ducatman A. Association between six environmental chemicals and lung cancer incidence in the United States. J Environ Public Health;2011;2011:463701.","DOI":"10.1155\/2011\/463701"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00440-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-020-00440-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00440-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T20:45:28Z","timestamp":1606164328000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-020-00440-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1186\/s12954-020-00440-w","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Goniewicz received research grant from Pfizer and personal fees from Johnson and Johnson, outside of this work. Other authors have nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}